Glucose News and Research

RSS

Prenatal POP exposure may increase the risk of metabolic disorders in adolescence

Exposure before birth to persistent organic pollutants (POPs)-- organochlorine pesticides, industrial chemicals, etc.--may increase the risk in adolescence of metabolic disorders, such as obesity and high blood pressure.

29 Apr 2021

Cholestenone could be a new antibacterial drug against H. pylori

Helicobacter pylori (H. pylori), a gram-negative pathogen that has infected half of the world's population is a Group I carcinogen according to the WHO. H. pylori resides in the gastric mucosa causing gastritis, ulcers, gastric cancers and malignant lymphoma of the stomach.

27 Apr 2021

UVA's imaging approach could help identify brain surgery targets to stop epilepsy seizures

An advanced imaging approach developed at the University of Virginia School of Medicine could let surgeons determine the best target in the brain to stop epilepsy seizures, new research suggests.

27 Apr 2021

Study reveals a hidden role of circulating microRNA as a driver of SARS-CoV-2 infection

In a methodological tour-de-force study, a large group of researchers from the USA and the United Kingdom analyzed patient transcriptomic data in-depth and discovered a circulating microRNA (miR-2392) that is directly implicated in the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) machinery during the infection process.

26 Apr 2021

Surge of pediatric patients with diabetic ketoacidosis during COVID-19 pandemic

According to the Centers for Disease Control and Prevention (CDC), children generally appear to be less severely impacted by COVID-19 than adults.

26 Apr 2021

Study may provide a basis for oral insulin development using DNP peptides

Researchers from Kumamoto University, Japan have found that DNP peptide, a small intestine-permeable cyclic peptide originally used as an insulin additive to improve absorption into the small intestinal, lowers blood glucose levels in mice.

26 Apr 2021

Hormonal therapies for breast and prostate cancers increase the risk of heart attack, stroke

The hormonal therapies used to treat many breast and prostate cancers raise the risk of a heart attack and stroke, and patients should be monitored regularly and receive treatment to reduce risk and detect problems as they occur.

26 Apr 2021

Clinical trial examines metabolic effects of natural compound NMN in people

A natural compound previously demonstrated to counteract aspects of aging and improve metabolic health in mice has clinically relevant effects in people, according to new research at Washington University School of Medicine in St. Louis.

22 Apr 2021

UTHSC researchers receive $1.99 million to advance understanding of diabetes pathophysiology

The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded a team of UTHSC researchers $1.99 million for their work to advance understanding of the pathophysiology of prediabetes, diabetes, and related complications.

22 Apr 2021

Once-a-week injectable insulin therapy proves to be safe, effective in people with Type 2 diabetes

Treating people with Type 2 diabetes with a new once-a-week injectable insulin therapy proved to be safe and as effective as daily insulin injections, according to the results of two international clinical trials published online today in Diabetes Care.

19 Apr 2021

Five-year study aims to improve health of patients with cystic fibrosis across their growing lifespan

People with cystic fibrosis are living better and longer, and now investigators want to further enhance quality and longevity by better understanding the role of nutrition, body composition and exercise in their health across an increasing lifespan.

19 Apr 2021

WHO’s new initiative aims to speed up action on diabetes

The World Health Organization's new Global Diabetes Compact aims to bring a much-needed boost to efforts to prevent diabetes and bring treatment to all who need it ̶ 100 years after the discovery of insulin.

16 Apr 2021

Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities

The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents for their anti-cancer potential, according to researchers at Massachusetts General Hospital (MGH).

15 Apr 2021

New wireless implant can help measure oxygen levels deep inside the body

Engineers at the University of California, Berkeley, have created a tiny wireless implant that can provide real-time measurements of tissue oxygen levels deep underneath the skin.

15 Apr 2021

Gene therapy may offer a new approach to preserving vision in people with retinitis pigmentosa

A gene therapy protects eye cells in mice with a rare disorder that causes vision loss, especially when used in combination with other gene therapies, shows a study published today in eLife.

13 Apr 2021

People who experience big dips in blood sugar levels consume more calories

New research shows that people who experience big dips in blood sugar levels, several hours after eating, end up feeling hungrier and consuming hundreds more calories during the day than others.

13 Apr 2021

Early cardiac events pose major and different risks in close relatives, finds study

Family history of early cardiac events in first degree relatives such as a parent or sibling is a major risk factor, especially for premature events. Currently, data on risks in close relatives of patients with a family history of premature heart attacks, chronic stable angina or peripheral vascular disease are sparse.

12 Apr 2021

Obesity reduces mitochondrial gene expression in fat tissue, finds study

A twin study recently completed at the University of Helsinki indicates that the machinery responsible for energy handling in fat tissue is working poorly in obesity.

9 Apr 2021

Researchers uncover new metabolic capabilities of gut bacteria

An international team of scientists led by microbiologists Alexander Loy from the University of Vienna and David Schleheck from the University of Konstanz has uncovered new metabolic capabilities of gut bacteria.

9 Apr 2021

Intermountain partners with University of Utah to jointly develop new medical educational program

Intermountain Healthcare is working on a transformative model for the future of healthcare called population health that focuses on keeping people in communities healthy and pre-emptively addressing cause of illnesses, rather than just treating people when they are sick.

9 Apr 2021

Glucose News and Research

Prenatal POP exposure may increase the risk of metabolic disorders in adolescence

Cholestenone could be a new antibacterial drug against H. pylori

UVA's imaging approach could help identify brain surgery targets to stop epilepsy seizures

Study reveals a hidden role of circulating microRNA as a driver of SARS-CoV-2 infection

Surge of pediatric patients with diabetic ketoacidosis during COVID-19 pandemic

Study may provide a basis for oral insulin development using DNP peptides

Hormonal therapies for breast and prostate cancers increase the risk of heart attack, stroke

Clinical trial examines metabolic effects of natural compound NMN in people

UTHSC researchers receive $1.99 million to advance understanding of diabetes pathophysiology

Once-a-week injectable insulin therapy proves to be safe, effective in people with Type 2 diabetes

Five-year study aims to improve health of patients with cystic fibrosis across their growing lifespan

WHO’s new initiative aims to speed up action on diabetes

Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities

New wireless implant can help measure oxygen levels deep inside the body

Gene therapy may offer a new approach to preserving vision in people with retinitis pigmentosa

People who experience big dips in blood sugar levels consume more calories

Early cardiac events pose major and different risks in close relatives, finds study

Obesity reduces mitochondrial gene expression in fat tissue, finds study

Researchers uncover new metabolic capabilities of gut bacteria

Intermountain partners with University of Utah to jointly develop new medical educational program

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News